Ahead of key meeting, FDA appears open to full approval of Alzheimer’s drug Leqembi

Ahead of key meeting, FDA appears open to full approval of Alzheimer’s drug Leqembi

Submitted by admin on June 7, 2023 - 9:53pm
Source: 
BioPharma Dive
News Tags: 
FDA
Eisai
Biogen
Leqembi
Alzheimer's disease
Headline: 
Ahead of key meeting, FDA appears open to full approval of Alzheimer’s drug Leqembi
snippet: 

Briefing documents released Wednesday indicate that agency staff seem confident in the drug’s benefits and the ability to mitigate its associated safety risks.

Do Not Allow Advertisers to Use My Personal information